# Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers

> **NCT04856969** · PHASE1 · COMPLETED · sponsor: **Autotelicbio** · enrollment: 38 (actual)

## Conditions studied

- Healthy Adult Volunteers

## Interventions

- **DRUG:** Olmesartan
- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT04856969
- **Lead sponsor:** Autotelicbio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-30
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-05-04
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04856969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04856969, "Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04856969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*